Startup Profile: Lactiga (020)

Episode 20 • September 05, 2021 • 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 5

October 06, 2023 • 00:19:44
Episode Cover

Beam Wellness - Blanketing Red Light Therapy

Beam Wellness was born out of the CEO's experience as a marketer in the cosmetic industry. It's now being incubated at Health Wildcatters in...

Listen

Episode 4

August 23, 2023 • 00:25:13
Episode Cover

Torque3: Advancing Stroke Rehabilitation w/ VR

Torque3 is developing a neurorehabilitation solution that has shown in early testing to result in significantly better recovery outcomes.  A wealth of research over...

Listen

Episode 2

July 21, 2023 • 00:52:56
Episode Cover

Track, Hockey & Kids - Richard Lehman, MD (Orthopedic Surgeon )

Richard Lehman, MD does not let moss grow under his feet. As you will hear in this episode, he is involved in the whole...

Listen